IBIO
USDiBio Inc. Common Stock
Prix en Temps Réel
Graphique des Prix
Métriques Clés
Métriques de Marché
Ouverture
$1.760
Haut
$1.760
Bas
$1.515
Volume
1.59M
Fondamentaux de l'Entreprise
Capitalisation Boursière
31.4M
Industrie
Biotechnologie
Pays
United States
Statistiques de Trading
Volume Moyen
3.38M
Bourse
NCM
Devise
USD
Intervalle sur 52 Semaines
Actualités Connexes
iBio Unveils New Non-Human Primate Data on IBIO-610, an Activin E Antibody with Strong Therapeutic Potential for Fat-Selective Weight-Loss and Weight Maintenance
Previously reported data showed that in a diet-induced obesity mouse model, IBIO-610 drives fat-selective, GLP-1-synergistic weight loss and prevents weight regain following GLP-1 treatment discontinuation New non-human
iBio to Participate in the Guggenheim 2nd Annual Healthcare Innovation Conference
SAN DIEGO, Oct. 23, 2025 (GLOBE NEWSWIRE) -- iBio, Inc. (NASDAQ:IBIO), an AI-driven innovator of precision antibody therapies, today announced that it will participate in the Guggenheim 2nd Annual Healthcare Innovation
iBio to Present New Preclinical Data on Its Activin E Antibody at Two Upcoming Scientific Conferences, ObesityWeek® and PEGS Europe 2025
SAN DIEGO, Oct. 21, 2025 (GLOBE NEWSWIRE) -- iBio, Inc. (NASDAQ:IBIO), an AI-driven innovator of precision antibody therapies, today announced that Cory Schwartz, Ph.D., Director of Research and Early Development at
Actions Connexes
APDN
Applied DNA Sciences Inc.
RCB
Ready Capital Corporation 6.20% Senior Notes due 2026
UK
Ucommune International Ltd Ordinary Shares
HUMAW
Humacyte Inc. Warrant
AURA
Aura Biosciences Inc.
Restez Informé
Configurez des alertes de prix, recevez des mises à jour d'analyses IA et des actualités de marché en temps réel.